Revelation Biosciences In... (REVBW)
Revelation Biosciences Statistics
Share Statistics
Revelation Biosciences has 71.74M shares outstanding. The number of shares has increased by -99.42% in one year.
| 71.74M |
| -99.42% |
| -99.8% |
| 35.25% |
| n/a |
| n/a |
| n/a |
Short Selling Information
The latest short interest is 1.61K, so 0% of the outstanding shares have been sold short.
| 1.61K |
| n/a |
| n/a |
| 1 |
Valuation Ratios
The PE ratio is -0.17 and the forward PE ratio is null. Revelation Biosciences's PEG ratio is 0.
| -0.17 |
| n/a |
| 0 |
| n/a |
| 0 |
| -0.14 |
| 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Revelation Biosciences.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.
| 3.43 |
| 3.43 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| n/a |
| $-1,879,817 |
| 8 |
| 0 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -0.09, so Revelation Biosciences's price volatility has been lower than the market average.
| -0.09 |
| n/a |
| 0.01 |
| 0.01 |
| 41.55 |
| n/a |
Balance Sheet
The company has 6.5M in cash and 0 in debt, giving a net cash position of 6.5M.
| 6.5M |
| n/a |
| n/a |
| -40.51B |
| 3.97M |
| 2.84M |
Cash Flow
In the last 12 months, operating cash flow was -18.32M and capital expenditures -19.17K, giving a free cash flow of -18.34M.
| -18.32M |
| -19.17K |
| -18.34M |
| -52.93 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
REVBW does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -20.91 |
| 4 |